Cite
Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine
MLA
Nuria Dasí-Navarro, et al. “Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine.” Toxins, vol. 14, no. 10, Sept. 2022, p. 651. EBSCOhost, https://doi.org/10.3390/toxins14100651.
APA
Nuria Dasí-Navarro, Manuel Lozano, Sabrina Llop, Ana Esplugues, Alessandra Cimbalo, Guillermina Font, Lara Manyes, Jordi Mañes, & Pilar Vila-Donat. (2022). Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine. Toxins, 14(10), 651. https://doi.org/10.3390/toxins14100651
Chicago
Nuria Dasí-Navarro, Manuel Lozano, Sabrina Llop, Ana Esplugues, Alessandra Cimbalo, Guillermina Font, Lara Manyes, Jordi Mañes, and Pilar Vila-Donat. 2022. “Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine.” Toxins 14 (10): 651. doi:10.3390/toxins14100651.